PMID: 9631693Jun 19, 1998Paper

Asthma and aspirin

Allergie et immunologie
A Sonneville

Abstract

Aspirin was discovered by Gerhardt in 1853. The first signs of problems in the form of asthmatiform dyspnoea were described in 1911 by Gilbert, then Reed and Cookes. Fernand Widal described the symptomatic triad characteristic of "aspirin illness" in 1922 with the association of "nasal polyposis, severe asthma and aspirin intolerance". It was in 1975 that the role of inhibition of cyclo-oxygenase was emphasized in physiological interpretation of the illness. Since then, very important progress has been made not only in the analysis of the affection, but also in its control not only by a new approach to "nose-bronchus" relationship which have enabled development of a new strategy in the "ORL and pneumologists". If the methods of immuno-allergological investigations, and especially scanning imagery and endoscopy, have made possible a better control of "aspirin illness" it still remains that this last often remains corticosteroid dependent. Important progress is expected with the discovery of anti-leucotrienes and several groups have shown the value of anti-leucotrienes in the management of "aspirin illness" so leading to the hope that one day there will be a reduction in the efficient limiting dose of corticosteroids.

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

© 2022 Meta ULC. All rights reserved